Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


Last --
Change Today 0.00 / 0.00%
Volume 0.0
6090 On Other Exchanges
Symbol
Exchange
6090 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

human metabolome technologie (6090) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for HUMAN METABOLOME TECHNOLOGIE (6090)

Related News

No related news articles were found.

human metabolome technologie (6090) Related Businessweek News

No Related Businessweek News Found

human metabolome technologie (6090) Details

Human Metabolome Technologies, Inc. engages in contract analysis, biomarker discovery, and metabolome solution sales businesses in Japan. The company provides metabolome analysis services; research and development services in pharmaceutical, medical, food, and chemical fields; and temporary staffing services. It is also involved in search and commercialization of diagnostic biomarkers in the drug development field. The company was founded in 2003 and is headquartered in Tsuruoka, Japan.

59 Employees
Last Reported Date: 06/29/15
Founded in 2003

human metabolome technologie (6090) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

human metabolome technologie (6090) Key Developments

Human Metabolome Technologies, Inc. Reports Consolidated Earnings Results for the Second Quarter Ended September 2015; Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 2016

Human Metabolome Technologies, Inc. reported consolidated earnings results for the second quarter ended September 2015. For the quarter, the company reported net sales of ¥299 million, operating loss of ¥115 million, ordinary loss of ¥111 million, loss attributable to owners of parent of ¥110 million or ¥20.80 per share against net sales of ¥242 million, operating loss of ¥141 million, ordinary loss of ¥132 million, loss attributable to owners of parent of ¥135 million or ¥25.76 per share for the same quarter year ago. For the fiscal year ending March 2016, the company expected consolidated net sales of ¥900 million, operating income of ¥15 million, ordinary income of ¥18 million, profit attributable to owners of parent of ¥12 million, and earnings per share of ¥2.26.

Human Metabolome Technologies, Inc., Q2 2016 Earnings Call, Nov 20, 2015

Human Metabolome Technologies, Inc., Q2 2016 Earnings Call, Nov 20, 2015

Human Metabolome Technologies, Inc. to Report Q2, 2016 Results on Nov 11, 2015

Human Metabolome Technologies, Inc. announced that they will report Q2, 2016 results on Nov 11, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
6090:JP ¥834.00 JPY +24.00

6090 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 6090.
View Industry Companies
 

Industry Analysis

6090

Industry Average

Valuation 6090 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 6.0x
Price/Book 3.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales 4.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact HUMAN METABOLOME TECHNOLOGIE, please visit www.humanmetabolome.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.